A LONG TERM FOLLOW-UP STUDY INVESTIGATING HEALTH RELATED QUALITY OF LIFE AND RESOURCE USE IN SURVIVORS OF SEVERE SEPSIS: COMPARISON OF RECOMBINANT HUMAN ACTIVATED PROTEIN C TO STANDARD CARE.
Christopher J. Longo(McMaster University), Claudio M. Martin(Western University), Daren K. Heyland(Queen's University), Harold Fisher, Andrew G. Day(Kingston Health Sciences Centre), Robert Fowler(Sunnybrook Health Science Centre)
Cited by 2
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
What is an intensive care unit? A report of the task force of the World Federation of Societies of Intensive and Critical Care Medicine
|Journal of Critical Care|2016|841
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597